SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Healthcare IT

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2108976

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2108976

Population Health Management Market by Component (Software, Services), Functionality (Analytics, Care Management, Risk & Predictive Analytics, VBC), End User (Hospital, Clinic, Payer, Public Health, Employer), Organization Size - Global Forecast to 2031

PUBLISHED:
PAGES: 335 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The population health management market is projected to reach USD 98.41 billion by 2031 from USD 46.93 billion in 2026, at a CAGR of 16.0%. Market growth is primarily driven by the increasing shift toward value-based care, the rising prevalence of chronic diseases, and the growing need to improve patient outcomes while reducing healthcare costs. Healthcare providers, payers, government agencies, and employers are increasingly adopting population health management solutions to identify high-risk populations, enhance care coordination, manage chronic conditions, and support preventive care initiatives. The integration of clinical, claims, pharmacy, laboratory, and social determinants of health (SDOH) data enables organizations to generate actionable insights, improve risk stratification, and deliver personalized care.

Scope of the Report
Years Considered for the Study2026-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD billion)
SegmentsComponent, Functionality, Delivery Mode, Organization Size, End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Additionally, the growing adoption of cloud-based platforms, artificial intelligence (AI), predictive analytics, remote patient monitoring, and interoperable healthcare systems is strengthening population health management capabilities. As healthcare organizations continue to prioritize data-driven decision-making, care coordination, and value-based reimbursement models, demand for comprehensive PHM solutions is expected to accelerate throughout the forecast period.

Population Health Management Market - IMG1

"The software segment accounted for a larger share of the population health management market in 2025."

Based on component, the population health management market has been segmented into software and services. The software segment accounted for a larger market share in 2025, driven by the widespread adoption of population health platforms for risk stratification, care management, predictive analytics, patient engagement, and clinical decision support. Healthcare providers and payers are increasingly investing in software solutions to integrate clinical, claims, pharmacy, and social determinants of health (SDOH) data, enabling real-time population insights and improved care coordination. The growing transition toward value-based care, increasing adoption of cloud-based PHM platforms, and rising demand for AI-enabled analytics and interoperability have further strengthened the dominance of the software segment in the population health management market.

"The cloud-based segment is expected to exhibit the fastest growth during the forecast period."

Based on delivery mode, the population health management market has been segmented into cloud-based, on-premises, and hybrid models. Of these, the cloud-based segment is expected to record the fastest growth during the forecast period. This fast-paced growth is mainly driven by the increasing demand for scalable, cost-effective, and interoperable healthcare solutions that support value-based care initiatives. Cloud-based PHM platforms enable seamless integration of clinical, claims, pharmacy, laboratory, and social determinants of health (SDOH) data while providing real-time analytics, remote patient monitoring, and AI-driven insights. Their lower upfront costs, faster deployment, automatic software updates, and ability to securely share data across multiple care settings are encouraging widespread adoption among healthcare providers, payers, and public health organizations, making cloud-based deployment the fastest-growing segment in the population health management market.

"Asia Pacific is expected to register the highest growth rate during the forecast period."

Asia Pacific is expected to witness the highest CAGR in the population health management market during the forecast period. This high growth rate is mainly supported by the rapid digitalization of healthcare systems, increasing government initiatives promoting healthcare IT adoption, rising prevalence of chronic diseases, and expanding investments in healthcare infrastructure across countries such as China, India, Japan, Australia, and South Korea. The growing adoption of electronic health records (EHRs), cloud-based healthcare platforms, AI-powered analytics, and remote patient monitoring solutions is enabling healthcare organizations to improve care coordination and population health outcomes. Furthermore, increasing awareness of preventive healthcare, expanding health insurance coverage, and the transition toward value-based care are accelerating the adoption of population health management solutions across the region, making Asia Pacific the fastest-growing regional market during the forecast period.

The breakdown of primary participants is as given below:

  • By Company Type - Tier 1: 37%, Tier 2: 22%, and Tier 3: 41%
  • By Designation - C-level: 55%, Director-level: 20%, and Others: 25%
  • By Region - North America: 30%, Europe: 45%, Asia Pacific: 20%, Latin America: 3%, Middle East & Africa: 2%

Oracle (US), Veradigm LLC (US), Merative (US), Epic Systems Corporation (US), Koninklijke Philips N.V. (Netherlands), Health Catalyst (US), and Optum Inc. (US) are some of the key players in the population health management market.

The study includes an in-depth competitive analysis of these key market players, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the population health management market by component (Software, Services), functionality (Population Health Analytics, Care Management & Care Coordination, Risk Stratification & Predictive Analytics, Patient Engagement, Physician Engagement, Quality & Value-based Care Management, Interoperability & Data Integration, Others), delivery mode (Cloud-based, On-premises, Hybrid), organization size (Large Enterprises, Medium Enterprises, Small Enterprises), end user (Healthcare Providers [Hospitals & Health Systems, Physician Practices & Clinics, Other Healthcare Providers], Healthcare Payers [Private Payers, Public Payers], Government & Public Health Agencies, Employers, Life Sciences), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the population health management market. A detailed analysis of the key industry players has been done to provide insights into their business overview, software, and services; key strategies; and contracts, partnerships, agreements, new product & service launches, mergers & acquisitions, and recent developments associated with the population health management market. Competitive analysis of upcoming and established players in the population health management market ecosystem is covered in this report.

Reasons to Buy this Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the population health management market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • The report provides insights on the following pointers: Analysis of key drivers (Expansion of Value-based Care (VBC) and Risk-based Reimbursement Models, Growing Focus on Reducing Hospital Readmissions through Coordinated Care, Growing Adoption of AI-Driven Predictive Analytics within Healthcare Organizations, Increasing Availability of Interoperable Digital Health Data), restraints (Persistent Healthcare Data Interoperability Challenges, Rising Data Breach Concerns), opportunities (Integration of Social Determinants of Health (SDOH) into Population Health Strategies, Expansion of Remote Patient Monitoring and Virtual Care Programs, Growing Demand for AI-powered Care Management Automation), and challenges (Demonstrating Measurable Return on Investment (ROI), Clinical Workflow Integration and User Adoption) influencing the growth of the population health management market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the population health management market
  • Market Development: Comprehensive information about lucrative markets; the report analyses the population health management market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the population health management market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and software offerings of leading players like Oracle (US), Veradigm LLC (US), Merative (US), Epic Systems Corporation (US), Koninklijke Philips N.V. (Netherlands), i2i Population Health (US), Health Catalyst (US), and Optum Inc. (US), among others, in the population health management market.
Show more
Product Code: HIT 2429

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
  • 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
  • 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW
  • 3.2 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT AND REGION
  • 3.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Expansion of value-based care (VBC) and risk-based reimbursement models
      • 4.2.1.2 Growing focus on reducing hospital readmissions through coordinated care
      • 4.2.1.3 Growing adoption of AI-driven predictive analytics within healthcare organizations
      • 4.2.1.4 Increasing availability of interoperable digital health data
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Persistent healthcare data interoperability challenges
      • 4.2.2.2 Rising data breach concerns
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Integration of Social Determinants of Health (SDOH) into population health strategies
      • 4.2.3.2 Expansion of remote patient monitoring and virtual care programs
      • 4.2.3.3 Growing demand for AI-powered care management automation
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Demonstrating measurable return on investment
      • 4.2.4.2 Clinical workflow integration and user adoption
  • 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 BARGAINING POWER OF SUPPLIERS
    • 5.1.2 BARGAINING POWER OF BUYERS
    • 5.1.3 THREAT OF SUBSTITUTES
    • 5.1.4 THREAT OF NEW ENTRANTS
    • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INTRODUCTION
    • 5.2.2 GDP TRENDS AND FORECAST
    • 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
    • 5.3.2 TECHNOLOGY INPUTS & INFRASTRUCTURE
    • 5.3.3 PLATFORM DEVELOPMENT & INTEGRATION
    • 5.3.4 DISTRIBUTION
    • 5.3.5 MARKETING & SALES
    • 5.3.6 POST-SALES SERVICES
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY COMPONENT (2025)
    • 5.5.2 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY REGION (2025)
  • 5.6 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 CASE STUDY ANALYSIS
  • 5.10 IMPACT OF 2025 US TARIFF - POPULATION HEALTH MANAGEMENT MARKET
    • 5.10.1 INTRODUCTION
    • 5.10.2 KEY TARIFF RATES
    • 5.10.3 PRICE IMPACT ANALYSIS
    • 5.10.4 IMPACT ON COUNTRY/REGION
      • 5.10.4.1 US
      • 5.10.4.2 Europe
      • 5.10.4.3 Asia Pacific
    • 5.10.5 IMPACT ON END USERS
      • 5.10.5.1 Healthcare providers
      • 5.10.5.2 Healthcare payers
      • 5.10.5.3 Government & public health agencies
      • 5.10.5.4 Employers
      • 5.10.5.5 Life sciences

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

  • 6.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1 AI-POWERED PREDICTIVE ANALYTICS & RISK STRATIFICATION
    • 6.1.2 GENERATIVE AI & CLINICAL DECISION SUPPORT
    • 6.1.3 DIGITAL CARE MANAGEMENT & REMOTE PATIENT MONITORING (RPM)
  • 6.2 COMPLEMENTARY TECHNOLOGIES
    • 6.2.1 EHR, EMR, AND CLINICAL WORKFLOW INTEGRATION
    • 6.2.2 HEALTHCARE DATA PLATFORMS & INTEROPERABILITY (FHIR, HL7, APIS)
  • 6.3 ADJACENT TECHNOLOGIES
    • 6.3.1 VALUE-BASED CARE & CARE COORDINATION PLATFORMS
    • 6.3.2 SOCIAL DETERMINANTS OF HEALTH (SDOH) & COMMUNITY HEALTH PLATFORMS
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.5 PATENT ANALYSIS
    • 6.5.1 PATENT PUBLICATION TRENDS FOR POPULATION HEALTH MANAGEMENT MARKET
    • 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.6 FUTURE APPLICATIONS
    • 6.6.1 PRECISION POPULATION HEALTH & AI-DRIVEN RISK PREDICTION
    • 6.6.2 CONTINUOUS CARE ECOSYSTEMS THROUGH REMOTE MONITORING & DIGITAL THERAPEUTICS
    • 6.6.3 SOCIAL DETERMINANTS OF HEALTH (SDOH) INTELLIGENCE & COMMUNITY-BASED CARE ORCHESTRATION
  • 6.7 IMPACT OF AI/GEN AI ON POPULATION HEALTH MANAGEMENT MARKET
    • 6.7.1 INTRODUCTION
    • 6.7.2 MARKET POTENTIAL OF AI/GEN AI IN POPULATION HEALTH MANAGEMENT
    • 6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
      • 6.7.3.1 AI-powered claims management and revenue cycle optimization at Sentara Health
    • 6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
      • 6.7.4.1 Healthcare analytics market
      • 6.7.4.2 Healthcare interoperability market
      • 6.7.4.3 Remote patient monitoring market
    • 6.7.5 USER READINESS AND IMPACT ASSESSMENT
      • 6.7.5.1 User readiness
        • 6.7.5.1.1 Healthcare providers
        • 6.7.5.1.2 Healthcare payers
      • 6.7.5.2 Impact assessment
        • 6.7.5.2.1 User A: Healthcare providers
        • 6.7.5.2.2 User B: Healthcare payers

7 REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 REGULATORY FRAMEWORK
      • 7.1.2.1 North America
      • 7.1.2.2 Europe
      • 7.1.2.3 Asia Pacific
      • 7.1.2.4 Latin America
      • 7.1.2.5 Middle East & Africa
    • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

  • 8.1 INTRODUCTION
  • 8.2 DECISION-MAKING PROCESS
  • 8.3 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
    • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.3.2 BUYING CRITERIA
  • 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.5 UNMET NEEDS FROM VARIOUS END USERS
    • 8.5.1 UNMET NEEDS
    • 8.5.2 END-USER EXPECTATIONS
  • 8.6 MARKET PROFITABILITY

9 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT

  • 9.1 INTRODUCTION
  • 9.2 SOFTWARE
    • 9.2.1 AI-POWERED ANALYTICS PLATFORMS PROPEL PHM SOFTWARE ADOPTION ACROSS VALUE-BASED ECOSYSTEMS
  • 9.3 SERVICES
    • 9.3.1 MANAGED CARE COORDINATION SERVICES BRIDGE TECHNOLOGY GAPS ACROSS FRAGMENTED HEALTH SYSTEMS

10 POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY

  • 10.1 INTRODUCTION
  • 10.2 POPULATION HEALTH ANALYTICS
    • 10.2.1 REAL-WORLD DATA INTEGRATION FUELS ACTIONABLE ANALYTICS ACROSS ENTIRE PATIENT POPULATIONS
  • 10.3 CARE MANAGEMENT & CARE COORDINATION
    • 10.3.1 ACO EXPANSION AND RISK-BEARING PAYMENT MODELS DRIVE INVESTMENT
  • 10.4 RISK STRATIFICATION & PREDICTIVE ANALYTICS
    • 10.4.1 PREDICTIVE AI MODELS ENABLE EARLIER INTERVENTION AND PRECISION RISK MANAGEMENT AT SCALE
  • 10.5 PATIENT ENGAGEMENT
    • 10.5.1 DIGITAL PATIENT ACTIVATION PROGRAMS CLOSE CARE GAPS AND IMPROVE CHRONIC DISEASE OUTCOMES
  • 10.6 PHYSICIAN ENGAGEMENT
    • 10.6.1 CLINICAL DECISION SUPPORT AND QUALITY DASHBOARDS EMBEDDING PHM INTO DAILY PHYSICIAN WORKFLOWS
  • 10.7 QUALITY & VALUE-BASED CARE MANAGEMENT
    • 10.7.1 RECORD ACO SAVINGS AND EXPANDED VBC INCENTIVES ACCELERATE QUALITY MANAGEMENT PLATFORM ADOPTION
  • 10.8 INTEROPERABILITY & DATA INTEGRATION
    • 10.8.1 TEFCA EXPANSION AND FHIR STANDARDS STRENGTHENING INFRASTRUCTURE FOR PHM DATA EXCHANGE
  • 10.9 OTHER FUNCTIONALITIES
    • 10.9.1 PUBLIC HEALTH SURVEILLANCE MODERNIZATION AND SDOH INTEGRATION EXPAND MARKET BOUNDARIES

11 POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE

  • 11.1 INTRODUCTION
  • 11.2 CLOUD-BASED
    • 11.2.1 INTEROPERABILITY MANDATES AND VBC SCALABILITY DEMANDS CEMENT CLOUD AS DOMINANT DELIVERY MODEL
  • 11.3 ON-PREMISES
    • 11.3.1 DATA SOVEREIGNTY, LEGACY INTEGRATION, AND REGULATORY COMPLIANCE SUSTAIN ON-PREMISES DEPLOYMENT
  • 11.4 HYBRID
    • 11.4.1 CLINICAL DATA CONTROL AND ANALYTICS SCALABILITY BALANCED THROUGH INTEGRATED HYBRID ARCHITECTURES

12 POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE

  • 12.1 INTRODUCTION
  • 12.2 LARGE ENTERPRISES
    • 12.2.1 ENTERPRISE-WIDE DIGITAL TRANSFORMATION AND VALUE-BASED CARE INITIATIVES DRIVE MARKET LEADERSHIP
  • 12.3 MEDIUM ENTERPRISES
    • 12.3.1 INCREASING PARTICIPATION IN VALUE-BASED CARE DRIVES DEMAND FOR SCALABLE PHM SOLUTIONS
  • 12.4 SMALL ENTERPRISES
    • 12.4.1 SUBSCRIPTION-BASED DEPLOYMENT MODELS IMPROVE PHM ACCESSIBILITY AND MARKET PENETRATION

13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER

  • 13.1 INTRODUCTION
  • 13.2 HEALTHCARE PROVIDERS
    • 13.2.1 HOSPITALS & HEALTH SYSTEMS
      • 13.2.1.1 Hospital digital transformation programs accelerate enterprise PHM platform deployment
    • 13.2.2 PHYSICIAN PRACTICES & CLINICS
      • 13.2.2.1 Independent practice value-based contracting creating scaled demand
    • 13.2.3 OTHER HEALTHCARE PROVIDERS
      • 13.2.3.1 Post-acute, behavioral health, and FQHC providers expand PHM market reach
  • 13.3 HEALTHCARE PAYERS
    • 13.3.1 RISK-BASED CONTRACTING EXPANSION AND CHRONIC DISEASE COST BURDEN DRIVE SEGMENT
    • 13.3.2 PRIVATE PAYERS
      • 13.3.2.1 Commercial VBC contracts and rising employer premiums accelerate adoption
    • 13.3.3 PUBLIC PAYERS
      • 13.3.3.1 CMS ACO expansion and Medicaid managed care growth reshaping public payer infrastructure
  • 13.4 GOVERNMENT & PUBLIC HEALTH AGENCIES
    • 13.4.1 PUBLIC HEALTH DATA MODERNIZATION AND GLOBAL DIGITAL HEALTH PROGRAMS BOOST GROWTH
  • 13.5 EMPLOYERS
    • 13.5.1 ESCALATING HEALTH BENEFIT COSTS AND CHRONIC DISEASE BURDEN COMPELLING EMPLOYER PHM PROGRAM INVESTMENT
  • 13.6 LIFE SCIENCES
    • 13.6.1 REAL-WORLD EVIDENCE GENERATION AND PATIENT RECRUITMENT DRIVE PHM PLATFORM ADOPTION

14 POPULATION HEALTH MANAGEMENT MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 14.2.2 US
      • 14.2.2.1 Value-based care and digital health transformation drive population health management adoption
    • 14.2.3 CANADA
      • 14.2.3.1 Digital health modernization & interoperability accelerate market growth
  • 14.3 EUROPE
    • 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 14.3.2 GERMANY
      • 14.3.2.1 Health data utilization and digital care reforms advance population health management
    • 14.3.3 FRANCE
      • 14.3.3.1 National health data ecosystem and preventive healthcare accelerates market growth
    • 14.3.4 UK
      • 14.3.4.1 Integrated care systems and population health analytics transforming healthcare delivery
    • 14.3.5 ITALY
      • 14.3.5.1 Community healthcare transformation and digital care continuity strengthen market growth
    • 14.3.6 SPAIN
      • 14.3.6.1 Regional integrated care networks and chronic disease management drives market expansion
    • 14.3.7 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 14.4.2 CHINA
      • 14.4.2.1 Healthy China 2030 and AI-driven healthcare transformation accelerate market growth
    • 14.4.3 JAPAN
      • 14.4.3.1 Healthy aging and community-based integrated care drive healthcare transformation
    • 14.4.4 INDIA
      • 14.4.4.1 Ayushman Bharat and digital public health infrastructure drive integrated care delivery
    • 14.4.5 AUSTRALIA
      • 14.4.5.1 Primary healthcare networks and digital health initiatives drive preventive care
    • 14.4.6 SOUTH KOREA
      • 14.4.6.1 AI-enabled healthcare and digital health innovation drive personalized care
    • 14.4.7 REST OF ASIA PACIFIC
  • 14.5 LATIN AMERICA
    • 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 14.5.2 BRAZIL
      • 14.5.2.1 National Health Data Network (RNDS) and digital health transformation strengthen market
    • 14.5.3 MEXICO
      • 14.5.3.1 Electronic health record standardization and healthcare digitalization support market growth
    • 14.5.4 REST OF LATIN AMERICA
  • 14.6 MIDDLE EAST & AFRICA
    • 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 14.6.2 GCC COUNTRIES
      • 14.6.2.1 Saudi Arabia
        • 14.6.2.1.1 Vision 2030 and AI-enabled healthcare transformation advancing population health management
      • 14.6.2.2 UAE
        • 14.6.2.2.1 AI-driven healthcare and national health data platforms accelerating population health management
      • 14.6.2.3 Other GCC countries
        • 14.6.2.3.1 National healthcare diversification creating opportunities for population health management
    • 14.6.3 SOUTH AFRICA
      • 14.6.3.1 National health insurance and primary healthcare reforms drive market
    • 14.6.4 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

  • 15.1 INTRODUCTION
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 15.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET
  • 15.3 REVENUE SHARE ANALYSIS, 2021-2025
  • 15.4 MARKET SHARE ANALYSIS, 2025
  • 15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.5.1 STARS
    • 15.5.2 PERVASIVE PLAYERS
    • 15.5.3 EMERGING LEADERS
    • 15.5.4 PARTICIPANTS
    • 15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
      • 15.5.5.1 Company footprint
      • 15.5.5.2 Region footprint
      • 15.5.5.3 Component footprint
      • 15.5.5.4 Functionality footprint
      • 15.5.5.5 Delivery mode footprint
      • 15.5.5.6 End user footprint
  • 15.6 COMPANY EVALUATION MATRIX: STARTUPS /SMES, 2025
    • 15.6.1 PROGRESSIVE COMPANIES
    • 15.6.2 DYNAMIC COMPANIES
    • 15.6.3 STARTING BLOCKS
    • 15.6.4 RESPONSIVE COMPANIES
    • 15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
  • 15.7 COMPANY VALUATION & FINANCIAL METRICS
    • 15.7.1 FINANCIAL METRICS
    • 15.7.2 COMPANY VALUATION
  • 15.8 BRAND/SOFTWARE COMPARISON ANALYSIS
  • 15.9 COMPETITIVE SCENARIO
    • 15.9.1 PRODUCT LAUNCHES & DEVELOPMENTS
    • 15.9.2 DEALS
    • 15.9.3 OTHER DEVELOPMENTS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 ORACLE
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Product launches & approvals
        • 16.1.1.3.2 Deals
        • 16.1.1.3.3 Other developments
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Right to win
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses & competitive threats
    • 16.1.2 OPTUM, INC.
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Deals
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Right to win
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses & competitive threats
    • 16.1.3 KONINKLIJKE PHILIPS N.V.
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Product launches & approvals
        • 16.1.3.3.2 Deals
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Right to win
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses & competitive threats
    • 16.1.4 EPIC SYSTEMS CORPORATION
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products offered
      • 16.1.4.3 Recent developments
        • 16.1.4.3.1 Product launches & approvals
        • 16.1.4.3.2 Deals
      • 16.1.4.4 MnM view
        • 16.1.4.4.1 Right to win
        • 16.1.4.4.2 Strategic choices
        • 16.1.4.4.3 Weaknesses & competitive threats
    • 16.1.5 MERATIVE
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Deals
        • 16.1.5.3.2 Expansions
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Right to win
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses & competitive threats
    • 16.1.6 VERADIGM LLC
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Deals
        • 16.1.6.3.2 Other developments
    • 16.1.7 I2I POPULATION HEALTH
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Deals
    • 16.1.8 HEALTH CATALYST
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products offered
      • 16.1.8.3 Recent developments
        • 16.1.8.3.1 Product launches & approvals
        • 16.1.8.3.2 Deals
    • 16.1.9 CEDAR GATE TECHNOLOGIES
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products offered
      • 16.1.9.3 Recent developments
        • 16.1.9.3.1 Product launches & approvals
    • 16.1.10 ECLINICALWORKS
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products offered
      • 16.1.10.3 Recent developments
        • 16.1.10.3.1 Product launches & approvals
    • 16.1.11 ELLIGINT HEALTH
      • 16.1.11.1 Business overview
      • 16.1.11.2 Products offered
    • 16.1.12 MEDECISION
      • 16.1.12.1 Business overview
      • 16.1.12.2 Products offered
      • 16.1.12.3 Recent developments
        • 16.1.12.3.1 Product launches & approvals
        • 16.1.12.3.2 Deals
    • 16.1.13 ARCADIA
      • 16.1.13.1 Business overview
      • 16.1.13.2 Products offered
      • 16.1.13.3 Recent developments
        • 16.1.13.3.1 Deals
    • 16.1.14 ATHENAHEALTH
      • 16.1.14.1 Business overview
      • 16.1.14.2 Products offered
      • 16.1.14.3 Recent developments
        • 16.1.14.3.1 Deals
    • 16.1.15 COTIVITI, INC.
      • 16.1.15.1 Business overview
      • 16.1.15.2 Products offered
      • 16.1.15.3 Recent developments
        • 16.1.15.3.1 Deals
        • 16.1.15.3.2 Other developments
    • 16.1.16 NXGN MANAGEMENT, LLC. (NEXTGEN HEALTHCARE)
      • 16.1.16.1 Business overview
      • 16.1.16.2 Products offered
  • 16.2 OTHER PLAYERS
    • 16.2.1 MEDEANALYTICS, INC.
    • 16.2.2 CONIFER HEALTH SOLUTIONS
    • 16.2.3 LIGHTBEAM HEALTH SOLUTIONS
    • 16.2.4 INNOVACCER
    • 16.2.5 LUMERIS
    • 16.2.6 ZEOMEGA
    • 16.2.7 MILLIMAN MEDINSIGHT (A MILLIMAN COMPANY)
    • 16.2.8 PERSIVIA
    • 16.2.9 COLOR HEALTH, INC.

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH APPROACH
    • 17.1.1 SECONDARY RESEARCH
      • 17.1.1.1 Key data from secondary sources
    • 17.1.2 PRIMARY RESEARCH
      • 17.1.2.1 Primary sources
      • 17.1.2.2 Key data from primary sources
      • 17.1.2.3 Breakdown of primaries
      • 17.1.2.4 Insights from primary experts
  • 17.2 RESEARCH METHODOLOGY
  • 17.3 MARKET SIZE ESTIMATION
  • 17.4 MARKET BREAKDOWN DATA TRIANGULATION
  • 17.5 MARKET SHARE ESTIMATION
  • 17.6 STUDY ASSUMPTIONS
  • 17.7 RESEARCH LIMITATIONS
    • 17.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 17.8 RISK ASSESSMENT

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS
Show more
Product Code: HIT 2429

List of Tables

  • TABLE 1 EXCHANGE RATES USED FOR CONVERSION TO USD
  • TABLE 2 US: BIGGEST HEALTHCARE DATA BREACHES OF 2025
  • TABLE 3 HEALTHCARE EDI MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 POPULATION HEALTH MANAGEMENT MARKET: ROLE IN ECOSYSTEM
  • TABLE 5 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY COMPONENT (2025)
  • TABLE 6 INDICATIVE PRICE FOR POPULATION HEALTH MANAGEMENT SOLUTIONS, BY REGION (2025)
  • TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: KEY CONFERENCES & EVENTS, 2026-2027
  • TABLE 8 CASE 1: ACCELERATED VALUE-BASED CARE DELIVERY WITH AI-DRIVEN POPULATION HEALTH MANAGEMENT
  • TABLE 9 CASE 2: IMPROVED COMMUNITY HEALTH THROUGH DATA-DRIVEN POPULATION HEALTH ANALYTICS
  • TABLE 10 CASE 3: REDUCED EMERGENCY DEPARTMENT VISITS THROUGH AI-ENABLED POPULATION HEALTH MANAGEMENT
  • TABLE 11 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 12 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR POPULATION HEALTH MANAGEMENT MARKET
  • TABLE 13 POPULATION HEALTH MANAGEMENT MARKET: KEY PATENTS/PATENT APPLICATIONS
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REGULATORY SCENARIO OF NORTH AMERICA
  • TABLE 20 REGULATORY SCENARIO OF EUROPE
  • TABLE 21 REGULATORY SCENARIO OF ASIA PACIFIC
  • TABLE 22 REGULATORY SCENARIO OF LATIN AMERICA
  • TABLE 23 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%)
  • TABLE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 26 UNMET NEEDS IN POPULATION HEALTH MANAGEMENT MARKET
  • TABLE 27 END-USER EXPECTATIONS IN POPULATION HEALTH MANAGEMENT MARKET
  • TABLE 28 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 29 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 30 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 31 POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 32 POPULATION HEALTH ANALYTICS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 33 CARE MANAGEMENT & CARE COORDINATION: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 34 RISK STRATIFICATION & PREDICTIVE ANALYTICS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 35 PATIENT ENGAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 36 PHYSICIAN ENGAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 37 QUALITY & VALUE-BASED CARE MANAGEMENT: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 38 INTEROPERABILITY & DATA INTEGRATION: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 39 OTHER FUNCTIONALITIES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 40 POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 41 CLOUD-BASED: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 42 ON-PREMISES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 43 HYBRID: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 44 POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 45 POPULATION HEALTH MANAGEMENT MARKET FOR LARGE ENTERPRISES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 46 POPULATION HEALTH MANAGEMENT MARKET FOR MEDIUM ENTERPRISES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 47 POPULATION HEALTH MANAGEMENT MARKET FOR SMALL ENTERPRISES, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 48 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 49 POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 50 HEALTHCARE PROVIDERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 51 POPULATION HEALTH MANAGEMENT MARKET FOR HOSPITALS AND HEALTH SYSTEMS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 52 POPULATION HEALTH MANAGEMENT MARKET FOR PHYSICIAN PRACTICES & CLINICS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 53 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 54 POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 55 HEALTHCARE PAYERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 56 POPULATION HEALTH MANAGEMENT MARKET FOR PRIVATE PAYERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 57 POPULATION HEALTH MANAGEMENT MARKET FOR PUBLIC PAYERS, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 58 GOVERNMENT & PUBLIC HEALTH AGENCIES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 59 EMPLOYERS: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 60 LIFE SCIENCES: POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 61 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2024-2031 (USD MILLION)
  • TABLE 62 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 63 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 64 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 65 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 66 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 67 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 68 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 69 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 70 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 71 US: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 72 US: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 73 US: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 74 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 75 US: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 76 US: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 77 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 78 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 79 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 80 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 81 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 82 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 83 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 84 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 85 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 86 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 87 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 88 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 89 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 90 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 91 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 92 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 93 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 94 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 95 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 96 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 97 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 98 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 99 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 100 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 101 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 102 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 103 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 104 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 105 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 106 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 107 UK: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 108 UK: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 109 UK: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 110 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 111 UK: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 112 UK: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 113 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 114 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 115 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 116 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 117 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 118 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 119 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 120 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 121 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 122 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 123 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 124 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 125 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 126 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 127 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 128 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 129 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 130 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 131 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 132 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 133 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 142 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 143 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 144 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 145 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 146 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 147 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 148 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 149 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 150 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 151 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 152 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 153 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 154 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 155 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 156 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 157 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 158 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 159 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 160 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 161 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 162 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 163 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 164 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 165 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 166 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 167 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 168 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 169 AUSTRALIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 170 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 171 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 172 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 173 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 174 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 175 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 176 SOUTH KOREA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 177 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 184 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 185 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 186 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 187 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 188 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 189 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 190 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 191 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 192 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 193 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 194 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 195 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 196 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 197 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 198 BRAZIL: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 199 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 200 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 201 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 202 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 203 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 204 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 205 MEXICO: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 206 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 207 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 208 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 209 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 210 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 213 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 214 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 221 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 229 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 230 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 231 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 232 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 233 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 234 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 235 SAUDI ARABIA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 236 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 237 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 238 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 239 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 240 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 241 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 242 UAE: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 243 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 244 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 245 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 246 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 247 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 248 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 249 OTHER GCC COUNTRIES: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 250 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 251 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 252 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 253 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 254 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 255 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 256 SOUTH AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 257 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2024-2031 (USD MILLION)
  • TABLE 258 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY FUNCTIONALITY, 2024-2031 (USD MILLION)
  • TABLE 259 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY DELIVERY MODE, 2024-2031 (USD MILLION)
  • TABLE 260 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY ORGANIZATION SIZE, 2024-2031 (USD MILLION)
  • TABLE 261 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2024-2031 (USD MILLION)
  • TABLE 262 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PROVIDER, 2024-2031 (USD MILLION)
  • TABLE 263 REST OF MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY HEALTHCARE PAYER, 2024-2031 (USD MILLION)
  • TABLE 264 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
  • TABLE 265 POPULATION HEALTH MANAGEMENT MARKET: DEGREE OF COMPETITION
  • TABLE 266 POPULATION HEALTH MANAGEMENT MARKET: REGION FOOTPRINT
  • TABLE 267 POPULATION HEALTH MANAGEMENT MARKET: COMPONENT FOOTPRINT
  • TABLE 268 POPULATION HEALTH MANAGEMENT MARKET: FUNCTIONALITY ANALYSIS
  • TABLE 269 POPULATION HEALTH MANAGEMENT MARKET: DELIVERY MODE FOOTPRINT
  • TABLE 270 END USER FOOTPRINT ANALYSIS
  • TABLE 271 POPULATION HEALTH MANAGEMENT MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 272 KEY EMERGING PLAYERS/STARTUPS: REGION FOOTPRINT
  • TABLE 273 KEY EMERGING PLAYERS/STARTUPS: COMPONENT FOOTPRINT
  • TABLE 274 KEY EMERGING PLAYERS/STARTUPS: FUNCTIONALITY FOOTPRINT
  • TABLE 275 KEY EMERGING PLAYERS/STARTUPS: DELIVERY MODE FOOTPRINT
  • TABLE 276 KEY EMERGING PLAYERS/STARTUPS: END USER FOOTPRINT
  • TABLE 277 POPULATION HEALTH MANAGEMENT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 278 POPULATION HEALTH MANAGEMENT MARKET: DEALS, JANUARY 2023-JULY 2026
  • TABLE 279 POPULATION HEALTH MANAGEMENT MARKET: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 280 ORACLE: COMPANY OVERVIEW
  • TABLE 281 ORACLE: PRODUCTS OFFERED
  • TABLE 282 ORACLE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 283 ORACLE: DEALS, JANUARY 2023-JULY 2026
  • TABLE 284 ORACLE: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 285 OPTUM INC.: COMPANY OVERVIEW
  • TABLE 286 OPTUM, INC.: PRODUCTS OFFERED
  • TABLE 287 OPTUM, INC.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 288 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 289 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 290 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 291 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-JULY 2026
  • TABLE 292 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 293 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED
  • TABLE 294 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 295 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023-JULY 2026
  • TABLE 296 MERATIVE: COMPANY OVERVIEW
  • TABLE 297 MERATIVE: PRODUCTS OFFERED
  • TABLE 298 MERATIVE: DEALS, JANUARY 2023-JULY2026
  • TABLE 299 MERATIVE: EXPANSIONS, JANUARY 2023-JULY 2026
  • TABLE 300 VERADIGM LLC: COMPANY OVERVIEW
  • TABLE 301 VERADIGM LLC: PRODUCTS OFFERED
  • TABLE 302 VERADIGM LLC: DEALS, JANUARY 2023-JULY 2026
  • TABLE 303 VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 304 I2I POPULATION HEALTH: COMPANY OVERVIEW
  • TABLE 305 I2I POPULATION HEALTH: PRODUCTS OFFERED
  • TABLE 306 I2I POPULATION HEALTH: DEALS, JANUARY 2023-JULY 2026
  • TABLE 307 HEALTH CATALYST: COMPANY OVERVIEW
  • TABLE 308 HEALTH CATALYST: PRODUCTS OFFERED
  • TABLE 309 HEALTH CATALYST: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 310 HEALTH CATALYST: DEALS, JANUARY 2023-JULY 2026
  • TABLE 311 CEDAR GATE TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 312 CEDAR GATE TECHNOLOGIES: PRODUCTS OFFERED
  • TABLE 313 CEDAR GATE TECHNOLOGIES: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 314 ECLINICALWORKS: COMPANY OVERVIEW
  • TABLE 315 ECLINICALWORKS: PRODUCTS OFFERED
  • TABLE 316 ECLINICALWORKS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 317 ELLIGINT HEALTH: COMPANY OVERVIEW
  • TABLE 318 ELLIGINT HEALTH: PRODUCTS OFFERED
  • TABLE 319 MEDECISION: COMPANY OVERVIEW
  • TABLE 320 MEDECISION: PRODUCTS OFFERED
  • TABLE 321 MEDECISION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-JULY 2026
  • TABLE 322 MEDECISION: DEALS, JANUARY 2023-JULY 2026
  • TABLE 323 ARCADIA: COMPANY OVERVIEW
  • TABLE 324 ARCADIA: PRODUCTS OFFERED
  • TABLE 325 ARCADIA: DEALS, JANUARY 2023-JULY 2026
  • TABLE 326 ATHENAHEALTH: COMPANY OVERVIEW
  • TABLE 327 ATHENAHEALTH: PRODUCTS OFFERED
  • TABLE 328 ATHENAHEALTH: DEALS, JANUARY 2023-JULY 2026
  • TABLE 329 COTIVITI, INC.: COMPANY OVERVIEW
  • TABLE 330 COTIVITI, INC.: PRODUCTS OFFERED
  • TABLE 331 COTIVITI, INC.: DEALS, JANUARY 2023-MAY 2026
  • TABLE 332 COTIVITI, INC.: OTHER DEVELOPMENTS, JANUARY 2023-JULY 2026
  • TABLE 333 NXGN MANAGEMENT, LLC.: COMPANY OVERVIEW
  • TABLE 334 NXGN MANAGEMENT, LLC.: PRODUCTS OFFERED
  • TABLE 335 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET

List of Figures

  • FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET SEGMENTATION
  • FIGURE 2 MARKET SCENARIO
  • FIGURE 3 GLOBAL POPULATION HEALTH MANAGEMENT MARKET, 2024-2031
  • FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET, 2023-2026
  • FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF POPULATION HEALTH MANAGEMENT MARKET
  • FIGURE 6 HIGH-GROWTH SEGMENTS IN POPULATION HEALTH MANAGEMENT MARKET, 2026-2031
  • FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN POPULATION HEALTH MANAGEMENT MARKET DURING FORECAST PERIOD
  • FIGURE 8 VALUE-BASED CARE AND HEALTHCARE DIGITALIZATION ACCELERATING GROWTH IN POPULATION HEALTH MANAGEMENT MARKET
  • FIGURE 9 SERVICES ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025
  • FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12 HEALTHCARE DATA BREACH ATTACK VECTORS, 2025
  • FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 15 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 18 PATENT PUBLICATION TRENDS IN POPULATION HEALTH MANAGEMENT MARKET, 2015-2026
  • FIGURE 19 JURISDICTION AND TOP APPLICANT ANALYSIS FOR POPULATION HEALTH MANAGEMENT MARKET
  • FIGURE 20 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2015 TO JULY 2026)
  • FIGURE 21 MARKET POTENTIAL OF AI/GEN AI ON POPULATION HEALTH MANAGEMENT SOLUTIONS ACROSS INDUSTRIES
  • FIGURE 22 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 25 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
  • FIGURE 26 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
  • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN POPULATION HEALTH MANAGEMENT MARKET, 2021-2025 (USD BILLION)
  • FIGURE 28 POPULATION HEALTH MANAGEMENT: MARKET SHARE ANALYSIS, 2025
  • FIGURE 29 POPULATION HEALTH MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 30 POPULATION HEALTH MANAGEMENT MARKET: COMPANY FOOTPRINT
  • FIGURE 31 POPULATION HEALTH MANAGEMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 32 EV/EBITDA OF KEY VENDORS
  • FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF POPULATION HEALTH MANAGEMENT SOLUTION VENDORS
  • FIGURE 34 POPULATION HEALTH MANAGEMENT MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
  • FIGURE 35 ORACLE: COMPANY SNAPSHOT (2025)
  • FIGURE 36 OPTUM, INC.: COMPANY SNAPSHOT (2025)
  • FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
  • FIGURE 38 VERADIGM LLC: COMPANY SNAPSHOT (2025)
  • FIGURE 39 HEALTH CATALYST: COMPANY SNAPSHOT (2025)
  • FIGURE 40 RESEARCH DESIGN
  • FIGURE 41 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 42 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 43 BOTTOM-UP APPROACH
  • FIGURE 44 TOP-DOWN APPROACH
  • FIGURE 45 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF POPULATION HEALTH MANAGEMENT SOLUTIONS INDUSTRY
  • FIGURE 46 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 47 DATA TRIANGULATION METHODOLOGY
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!